Find and Pitch Jounalists, Get Your Story Covered

Tags: Acino M8 Pharmaceuticals acquisition Camber Pharmaceuticals Generic Alesse

	Profile	Recent Articles on Subject
1	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Advancing Patient Safety and Health Care Efficiency: The Critical Role of Pharmacists - 6 days ago Turning the Page - about 1 month ago Transforming Cancer Care: Innovations in Immunotherapy and the Critical Role of the Pharmacist - 5 months ago Securing Patient Trust: Advancing Cybersecurity and Training in Health-System Pharmacies - 6 months ago Pharmacists Are Vital to Heart Health - 12 months ago Assessing the Cognitive Consequences of Certain Medicines Remains a Challenge - about 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - about 1 month ago Pharma takes aim at a wily foe — the Epstein-Barr virus - 3 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 3 months ago 2024 PharmaVoice 100s: Trailblazers - 3 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 5 months ago Is anyone taking the world’s priciest drugs? - 5 months ago Neuro drugs are still faltering, despite rising investment - 6 months ago Where competition is heating up in pharma - 8 months ago The biggest questions hanging over pharma in 2024 - 12 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 3 standout digital innovations in pharma this year - about 1 year ago PharmaVoice 100s: Entrepreneurs - about 1 year ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The first MASH drug could open the door for others — including GLP-1s - 2 months ago From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies - 2 months ago 3 FDA approval dates to watch in the year’s final push - 4 months ago BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 5 months ago As the GLP-1 market booms, other healthcare companies are cashing in - 7 months ago Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? - 8 months ago As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene - 10 months ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 2 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - 3 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 10 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 11 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - about 1 year ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - about 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - about 1 year ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - about 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - over 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - over 1 year ago
5	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 4 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Condition Watch, August 2024: Dermatology - 5 months ago Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 5 months ago Digital Therapeutics Might Address Gaps in Care for Mental Health Patients - 10 months ago Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals - 11 months ago Key Market Trends for the Current Specialty Drug Pipeline - over 1 year ago Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages - over 1 year ago
7	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	June 2024 Products Column - 7 months ago
8	Deanna Fox, PharmD Pharmacy Times Former journalist. Now comms exec. Capital Region, New York communications	OTC Case Studies: Contraception - 8 months ago
9	Jennifer Gershman, PharmD, CPh, PACS Pharmacy Times Pharmacist. Writes for Pharmacy Times, GoodRx. PharmacyHealthcare	Pharmacists Make Positive Impact Through Clinical Interventions - 10 months ago
10	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	2024 - 12 months ago

Journalists covering pharmaceuticals